Review on Novel Monoamine Oxidase Inhibitors: A Clinician’s Guide

Journal Title: Open Access Journal of Pharmaceutical Research - Year 2021, Vol 5, Issue 2

Abstract

The purpose of this review is to provide information on the mechanisms of action, pharmacokinetics, therapeutic effectiveness, safety, and tolerability of four novel antidepressants: pirlindole, safinamide, selegiline, and toloxatone. In spite of the initial pharmacological interest, monoamine oxidase (MAO) inhibitors are used in clinics for their antidepressant effects and in the treatment of Parkinson’s syndrome due to proven neuroprotective effects. Patients with a lack of efficacy or tolerability for some monoamine oxidase inhibitors may benefit from the option of a new one monoamine oxidase inhibitors with various mechanism of actions. In the selection of newer monoamine oxidase inhibitors, these drugs may be an alternative. The simple deficiency of serotonin in the brain does not cause depression, but rather a complex interplay of different neurotransmitters, including some regions of the brain include serotonin, norepinephrine, dopamine and histamine. The novel monoamine oxidase inhibitors described above exert their therapeutic advantages by acting on multiple neurotransmitters. When formulating a plan of treatment, the ambiguity of the underlying neurobiological process should be considered.

Authors and Affiliations

Patil AJ and Suryawanshi MR*

Keywords

Related Articles

A Glance on Lemon Grass-Extraction, Applications and Uses

Lemongrass is widely available herb belonging to family Poaceae having biological souse leaf of plant Cymbopogon Citratus. The name Lemon originates from its typical odour, because of presence of citral a cyclic monoter...

The Influence of Cholinergic System on Rheumatoid Arthritis

Rheumatoid arthritis is one of the most prevalent immune-mediated arthritis and is categorized as a chronic, inflammatory and autoimmune disease, which mainly affects the cartilage, synovial joint, and bone, the causes o...

Assessment of Self-Medication and Disease Awareness about Migraine in Local Community of Multan, Pakistan

Background: Self-Medication and Poor disease awareness of Migraine is the furthermost public well-being concern in many countries, as well as in Pakistan. Thus considering the current epidemiological evidence about that...

Antihyperlipidemic and Antibacterial Activities of Baccaurea Courtallensis Leaves

The present study evaluated the antihyperlipidemic and antibacterial activities of B. courtallensis extract. The antihyperlipidemic effect of B. courtallensis methanol extract was studied in Triton WR-1339 and high fat d...

Symptoms, Precaution and Prevention for COVID-19

In early 2020, another infection started creating features everywhere throughout the world in light of the exceptional speed of its transmission. Its inceptions have been followed to a food showcase in Wuhan, China, in...

Download PDF file
  • EP ID EP748568
  • DOI 10.23880/oajpr-16000240
  • Views 60
  • Downloads 0

How To Cite

Patil AJ and Suryawanshi MR* (2021). Review on Novel Monoamine Oxidase Inhibitors: A Clinician’s Guide. Open Access Journal of Pharmaceutical Research, 5(2), -. https://www.europub.co.uk/articles/-A-748568